CINECA IRIS Institutional Research Information System

PIZZIMENTI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.527
EU - Europa 4.189
AS - Asia 2.484
AF - Africa 79
SA - Sud America 48
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 13.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.435
IT - Italia 1.836
CN - Cina 1.271
SE - Svezia 451
SG - Singapore 447
IE - Irlanda 377
DE - Germania 241
FR - Francia 241
UA - Ucraina 183
FI - Finlandia 179
GB - Regno Unito 164
KR - Corea 164
JP - Giappone 119
VN - Vietnam 110
PL - Polonia 102
AT - Austria 99
TW - Taiwan 88
IN - India 86
CA - Canada 71
ID - Indonesia 57
NL - Olanda 51
BE - Belgio 39
SN - Senegal 37
HK - Hong Kong 36
DK - Danimarca 35
ES - Italia 32
RU - Federazione Russa 32
BR - Brasile 29
AU - Australia 26
TR - Turchia 23
IR - Iran 22
CH - Svizzera 21
ET - Etiopia 20
MX - Messico 20
RO - Romania 15
CZ - Repubblica Ceca 14
PT - Portogallo 14
EU - Europa 13
HR - Croazia 12
GR - Grecia 10
TH - Thailandia 10
HU - Ungheria 8
IL - Israele 8
UZ - Uzbekistan 8
BY - Bielorussia 7
EG - Egitto 7
PH - Filippine 7
BG - Bulgaria 6
CO - Colombia 6
AR - Argentina 5
IQ - Iraq 5
MY - Malesia 5
DZ - Algeria 4
PK - Pakistan 4
CL - Cile 3
MK - Macedonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
KE - Kenya 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NO - Norvegia 2
PE - Perù 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
EC - Ecuador 1
EE - Estonia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
OM - Oman 1
QA - Qatar 1
SA - Arabia Saudita 1
UY - Uruguay 1
ZA - Sudafrica 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 13.370
Salva come PNG Salva come JPEG
Città #
Chandler 877
Beijing 470
Torino 423
Fairfield 408
Dublin 374
Singapore 368
Houston 359
Ashburn 357
Jacksonville 223
Ann Arbor 221
Woodbridge 200
Wilmington 177
Nyköping 172
Santa Clara 166
Seattle 163
Villeurbanne 154
Cambridge 143
Dearborn 141
Redwood City 134
Medford 116
Princeton 111
Columbus 102
Pisa 99
Shanghai 98
Vienna 95
Milan 84
Warsaw 84
Fremont 82
Turin 77
Dong Ket 75
Guangzhou 73
Taipei 64
Rome 62
Nanjing 60
Jakarta 48
New York 46
Boardman 43
Boston 39
San Diego 33
Washington 33
Chengdu 31
Hangzhou 30
Munich 29
Los Angeles 28
Napoli 28
Shenyang 28
Brussels 27
Hefei 27
Verona 25
Changsha 23
Jinan 23
Seoul 22
Helsinki 20
Wuhan 20
Toronto 19
Xian 19
Silver Spring 17
Tokyo 17
Kunming 16
Phoenix 16
Florence 15
Serra 15
Tianjin 15
Norwalk 14
Parma 14
Bologna 13
Hebei 13
London 13
Zhengzhou 13
Amsterdam 12
Bari 12
Catania 12
Nanchang 12
Palermo 11
Chicago 10
Düsseldorf 10
Hong Kong 10
Lachine 10
Mumbai 10
Chongqing 9
Gloucester 9
Gravina In Puglia 9
Falls Church 8
Genova 8
Monmouth Junction 8
Montréal 8
São Paulo 8
Berlin 7
Dallas 7
Frankfurt am Main 7
Fuzhou 7
Guiyang 7
Harbin 7
Hyderabad 7
Moscow 7
Newcastle 7
Ottawa 7
Perugia 7
Piemonte 7
Piscataway 7
Totale 7.911
Salva come PNG Salva come JPEG
Nome #
Effetti del 4-idrossinonenale, un’aldeide prodotta dalla perossidazione lipidica, sull’espressione dei microRNA in cellule leucemiche umane HL-60 942
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases. 876
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 644
Drug delivery nanoparticles in treating chemoresistant tumor cells 395
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 330
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 327
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 267
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 266
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. 246
Drug Delivery Nanoparticles in Skin Cancers 229
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression 217
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 208
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 201
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage 201
3D advanced human melanoma models 195
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. 174
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 171
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products 168
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells 165
Effetti del 4-idrossinonenale, un prodotto della per ossidazione lipidica, sull’espressione e l’attività dell’enzima telomerasi in cellule leucemiche umane 164
4-hydroxynonenal and cell cycle 162
The Potential Therapeutic Target Nrf2 in Childhood Brain Tumors 155
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines 152
3D advanced melanoma models 151
In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research 143
Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells 143
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells 141
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment 133
4-idrossinonenale: un regolatore endogeno del potenziale replicativi delle cellule 125
Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. 124
Lipid peroxidation in colorectal carcinogenesis: bad and good news 123
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 114
Effect of Camptothecin nanosponges on anaplastic thyroid cancer models 112
Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. 109
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver 108
Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders 107
DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity 107
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line 105
Latest News on Nanotechnology for Melanoma Therapy and Diagnosis 103
4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells. 103
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells 102
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer 101
Camptothecin in nanosponges as new therapeutic delivery agent in prostate cancer: in vitro and in vivo evaluation 100
Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models 100
Rosiglitazone, Alone or in Combination with AS601245, an Anti-Inflammatory JNK Inhibitor, Affects Apoptosis, Differentiation and Cell Adhesion in CaCo-2 Human Colon Cancer Cells Through Modulation of Specific Gene Expressions. 99
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 98
Azione citotossica in vitro del colesterilbutirrato incorporato in nanoparticelle lipidiche solide 96
Identification of 4-Hydroxynonenal-alpha-enolase adducts in HL-60 human leukemic cells: inhibition of plasminogen binding 95
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. 93
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in orthotopic xenograft tumors in vivo 92
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 92
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines 90
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 90
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. 86
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network, in colon cancer cells 86
Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role 86
4-hydroxynonenal effects on telomerase activity and expression in leukemic cells 85
4-Hydroxynonenal (HNE), a product of lipid peroxidation, down-regulates hTERT expression and telomerase activity in leukemic cell, by modulating the relative trascription factor expression 85
Carbosilane dendrimers loaded with sirna targeting nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells 85
4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway 84
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 84
4-Hydroxynonenal (HNE), a product of lipide peroxidation, inhibits telomerase activity in Caco-2, a colon cancer cell line, by the inhibition of E-Box activity of the h-TERT promoter 84
MicroRNA expression profiling during human leukemic HL-60 cell differentiation induced by 4-Hydroxynonenal, a product of lipid peroxidation 82
Ruolo svolto dai prodotti della perossidazione lipidica e dai ligandi di PPAR sul controllo della crescita di cellule di carcinoma del colon 82
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 81
Enzymatic pattern of aldehyde metabolism during HL-60 cell differentiation. 79
4-Hydroxynonenal: an endogenous signal for cell proliferation and differentiation. 78
4-hydroxynonenal affects the proliferation and the apoptosis in SK-N-BE neuroblastoma cell line 78
4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity 77
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo in orthotopic xenograft tumors 75
4-Hydroxynonenal-induced MEL cell differentiation involves PKC activity translocation. 74
Hippo pathway effector Yes-associated protein and cisplatin resistance in transitional cell carcinoma of the bladder 74
PPAR gamma ligands and 4-hydroxinonenal affect growth, differentiation and apotosis in human caco-2 cells 73
Targeting Cell Cycle Through Combination of the Histone Deacetylase Inhibitor, LBH589,and Lipids Peroxidation End Product,4-Hydroxnonenal (HNE), in PC3 Prostate Cancer Cells. 73
Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell. 72
GSH-responsive nanoparticles in the treatment of tumor cells. 71
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells 71
Effect of bioactive aldehydes on cell proliferation and c-myc expression in HL-60 human leukemic cells. 70
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migartion Trhougt modulation of specific Gene Expression in Human Colon Cancer Cells. 70
Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity 70
Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies 70
4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells. 69
4-Hydroxynonenal action on cell cycle and differentiation. 69
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma 68
Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. 66
Evaluation of antiproliferative activity of cholesteryl butyrate solid lipid nanospheres on leukemic cell lines 65
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products 64
Combined antitumoral efficacy of the histone deacetilase inhibitor LBH589 and the lipid peroxidation end product 4-hydroxynonenal (HNE) on PC3 prostate cancer cell. 62
Mechanisms of telomerase activity and hTERT expression inhibition by HNE in human leukemic cells 61
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands inhibit telomerase activity and h-TERT expression in CaCo-2 colon cancer cells 61
Lipi peroxidation: control of cell proliferation, cell differentiation and cell death 60
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 59
Increase of telomerase activity and hTERT expression in myelodysplastic syndromes 58
Mechanism of c-myc expression inhibition by 4-hydroxynonenal,a product of lipid peroxidation 53
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells 53
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. 47
Non-Melanoma Skin Cancer: news from microbiota research 43
Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma 43
Enzymes metabolizing aldehydes in HL-60 human leukemic cells. 42
Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. 41
Totale 13.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.354
article - articoli 0
book - libri 0
conference - conferenze 9.079
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.436 0 0 0 0 119 279 241 186 223 165 113 110
2020/20211.726 130 117 120 113 151 130 137 101 234 135 149 209
2021/20221.437 81 69 58 105 70 55 59 61 78 125 396 280
2022/20232.289 221 209 55 298 186 556 121 152 226 70 116 79
2023/20241.366 146 181 109 118 90 157 78 106 14 94 130 143
2024/20251.065 49 132 137 273 474 0 0 0 0 0 0 0
Totale 13.776